Cover Image

A prospective study of health care resource utilisation and selected costs of schizophrenia in France

<p>Abstract</p> <p>Background</p> <p>Schizophrenia is among the most burdensome and costly illnesses worldwide. To estimate the cost of schizophrenia in France, a longitudinal study was carried out between 1998 and 2002. The main objective of this study was to describe...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sarlon Emmanuelle (Author), Heider Dirk (Author), Millier Aurélie (Author), Azorin Jean-Michel (Author), König Hans-Helmut (Author), Hansen Karina (Author), Angermeyer Matthias C (Author), Aballéa Samuel (Author), Toumi Mondher (Author)
Format:	Book
Published:	BMC, 2012-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Systematic review of utility values used in the pharmacoeconomic evaluations for schizophrenia: implications on cost-effectiveness results
by: Junwen Zhou, et al.
Published: (2019)

Systematic review of pharmacoeconomic models for schizophrenia
by: Junwen Zhou, et al.
Published: (2018)

Analysis of health economics assessment reports for pharmaceuticals in France - understanding the underlying philosophy of CEESP assessment
by: Mondher Toumi, et al.
Published: (2017)

Health related quality of life in patients having schizophrenia negative symptoms - a systematic review
by: Chiraz Azaiez, et al.
Published: (2018)

Healthcare resource use in schizophrenia, EuroSC findings
by: A. Millier, et al.
Published: (2017)

Commentary on "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial" by Gautret et al
by: Mondher Toumi, et al.
Published: (2020)

Measuring health-related quality of life in young children: how far have we come?
by: Nicola Germain, et al.
Published: (2019)

Real-world cost-effectiveness of rivaroxaban and apixaban vs VKA in stroke prevention in non-valvular atrial fibrillation in the UK
by: Kevin Bowrin, et al.
Published: (2020)

On the association between SARS-COV-2 variants and COVID-19 mortality during the second wave of the pandemic in Europe
by: Katarzyna Jabłońska, et al.
Published: (2021)

Allocating treatment resources for hepatitis C in the UK: a constrained optimization modelling approach
by: Ru Han, et al.
Published: (2021)

Income-, education- and gender-related inequalities in out-of-pocket health-care payments for 65+ patients - a systematic review
by: Corrieri Sandro, et al.
Published: (2010)

Are informal family caregivers stigmatized differently based on their gender or employment status?: a German study on public stigma towards informal long-term caregivers of older individuals
by: Larissa Zwar, et al.
Published: (2021)

Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies
by: Michal Pochopien, et al.
Published: (2019)

A tolerability burden index in schizophrenia: incorporating patient perspective in clinical trial adverse event reporting
by: Clément François, et al.
Published: (2017)

Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation
by: Craig I. Coleman, et al.
Published: (2019)

Welcome to the Journal of Market Access and Health Policy under MDPI Wings
by: Mondher Toumi
Published: (2024)

An overview of health technology assessments of gene therapies with the focus on cost-effectiveness models
by: Michał Pochopień, et al.
Published: (2021)

Health economic evaluation of gene replacement therapies: methodological issues and recommendations
by: Samuel Aballéa, et al.
Published: (2020)

'Broken souls' vs. 'mad ax man' - changes in the portrayal of depression and schizophrenia in the German media over 10 years
by: M. Sittner, et al.
Published: (2024)

Cost-Effectiveness Analysis of Innovative Therapies for Patients with Non-Alcoholic Fatty Liver Disease
by: Michal Pochopien, et al.
Published: (2024)

Diffusion et utilisation des TIC en France et en Europe
by: Pierre Berret

The burden of hospitalisations for COVID-19 in France: a study of all cases in the national insurance claims database in 2020
by: Claire Leboucher, et al.
Published: (2023)

Mapping the EORTC QLQ-C30 onto the EQ-5D-5L index for patients with paroxysmal nocturnal hemoglobinuria in France
by: Piotr Wojciechowski, et al.
Published: (2023)

Non-profit drug research and development: the case study of Genethon
by: Szymon Jarosławski, et al.
Published: (2019)

Value added medicines: what value repurposed medicines might bring to society?
by: Mondher Toumi, et al.
Published: (2017)

Market access agreements for pharmaceuticals in Europe: diversity of approaches and underlying concepts
by: Jarosławski Szymon, et al.
Published: (2011)

Diffusion et utilisation des TIC en France et en Europe en 2009
by: Valérie Deroin

Personality and oral health-related quality of life. Results from an online survey
by: André Hajek, et al.
Published: (2022)

Oral health-related quality of life, probable depression and probable anxiety: evidence from a representative survey in Germany
by: André Hajek, et al.
Published: (2022)

Frequency and Correlates of Online Consultations With Doctors or Therapists in Middle-Aged and Older Adults: Nationally Representative Cross-sectional Study
by: André Hajek, et al.
Published: (2022)

How do individuals rate their health compared to others? findings based on a nationally representative sample in Germany
by: André Hajek, et al.
Published: (2024)

Perceived ageism and psychosocial outcomes during the COVID-19 pandemic
by: André Hajek, et al.
Published: (2024)

Are perceived bad working conditions and perceived workplace bullying associated with doctor visits? Results of the nationally representative German General Social Survey
by: André Hajek, et al.
Published: (2019)

Personality-related and psychosocial correlates of sick leave days in Germany during the COVID-19 pandemic: findings of a representative survey
by: André Hajek, et al.
Published: (2022)

Which factors lead to frequent attendance in the outpatient sector among individuals in the second half of life? Evidence from a population-based longitudinal study in Germany
by: André Hajek, et al.
Published: (2018)

The association between use of online social networks sites and perceived social isolation among individuals in the second half of life: results based on a nationally representative sample in Germany
by: André Hajek, et al.
Published: (2019)

Expenditure and resource utilisation for cervical screening in Australia
by: Lew Jie-Bin, et al.
Published: (2012)

Impact of the COVID-19 pandemic on the conduct of clinical trials: a quantitative analysis
by: Wojciech Margas, et al.
Published: (2022)

Gene therapy randomised clinical trials in Europe - a review paper of methodology and design
by: Krassimira Ilieva, et al.
Published: (2020)

Characteristics of doctor-shoppers: a systematic literature review
by: Małgorzata Biernikiewicz, et al.
Published: (2019)